| Attributes | Values |
|---|
| rdf:type
| |
| description
| - wetenschappelijk artikel (nl)
- наукова стаття, опублікована в лютому 2000 (uk)
- im Februar 2000 veröffentlichter wissenschaftlicher Artikel (de)
- wüsseschaftlicher Artikel, wo im Hornig 2000 veröffentlicht worden isch (gsw)
- artículu científicu espublizáu en febreru de 2000 (ast)
- artikull shkencor i botuar më 01 shkurt 2000 (sq)
- scientific article published on 01 February 2000 (en)
- գիտական հոդված հրատարակված 2000 թվականի փետրվարի 1-ին (hy)
|
| publication date
| |
| publication date
| |
| author name string
| |
| author name string
| - A Takeshita
- K Miyata
- H Shimokawa
- K Egashira
- Y Takamura
- E Tanaka
- T Higo
- T Yamawaki
- K Yogo
- N Katsumata
- T Kandabashi
|
| rdfs:label
| - Sarpogrelate, a selective 5-HT2A serotonergic receptor antagonist, inhibits serotonin-induced coronary artery spasm in a porcine model (en)
- Sarpogrelate, a selective 5-HT2A serotonergic receptor antagonist, inhibits serotonin-induced coronary artery spasm in a porcine model (nl)
- Sarpogrelate, a selective 5-HT2A serotonergic receptor antagonist, inhibits serotonin-induced coronary artery spasm in a porcine model (sq)
|
| skos:prefLabel
| - Sarpogrelate, a selective 5-HT2A serotonergic receptor antagonist, inhibits serotonin-induced coronary artery spasm in a porcine model (en)
- Sarpogrelate, a selective 5-HT2A serotonergic receptor antagonist, inhibits serotonin-induced coronary artery spasm in a porcine model (nl)
- Sarpogrelate, a selective 5-HT2A serotonergic receptor antagonist, inhibits serotonin-induced coronary artery spasm in a porcine model (sq)
|
| name
| - Sarpogrelate, a selective 5-HT2A serotonergic receptor antagonist, inhibits serotonin-induced coronary artery spasm in a porcine model (en)
- Sarpogrelate, a selective 5-HT2A serotonergic receptor antagonist, inhibits serotonin-induced coronary artery spasm in a porcine model (nl)
- Sarpogrelate, a selective 5-HT2A serotonergic receptor antagonist, inhibits serotonin-induced coronary artery spasm in a porcine model (sq)
|
| title
| |
| title
| - Sarpogrelate, a selective 5-HT2A serotonergic receptor antagonist, inhibits serotonin-induced coronary artery spasm in a porcine model (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.1097/00005344-200002000-00018
|
| is about
of | |
| is cites work
of | - The prevention of contrast induced nephropathy by sarpogrelate in patients with chronic kidney disease: a study protocol for a prospective randomized controlled clinical trial
- Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modeling
- The role of 5-HT on the cardiovascular and renal systems and the clinical potential of 5-HT modulation
- Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers
- The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes
- Depression and cardiac disease: epidemiology, mechanisms, and diagnosis
- Sarpogrelate HCl, a selective 5-HT2A antagonist, retards the progression of atherosclerosis through a novel mechanism
- Increased Coronary Events in Depressed Cardiovascular Patients: 5-HT2A Receptor as Missing Link?
- Locally administered antiproliferative drugs inhibit hypercontractility to serotonin in balloon-injured pig coronary artery
- Sarpogrelate inhibits the expression of ICAM-1 and monocyte-endothelial adhesion induced by high glucose in human endothelial cells
- Anxiety Disorders and Cardiovascular Disease
- Upregulation of 5-hydroxytryptamine receptor signaling in coronary arteries after organ culture
- Inhibition of 5-Hydroxytryptamine Receptor 2B Reduced Vascular Restenosis and Mitigated the β-Arrestin2-Mammalian Target of Rapamycin/p70S6K Pathway.
- Angiotensin II, as well as 5-hydroxytriptamine, is a potent vasospasm inducer of saphenous vein graft for coronary artery bypass grafting in patients with diabetes mellitus
- The effects of vasodilators on the relaxation of guinea-pig aorta during acute recoil
- Refractory variant angina with a seasonal trend treated with sarpogrelate hydrochloride.
- 5-HT2 receptor blockade exhibits 5-HT vasodilator effects via nitric oxide, prostacyclin and ATP-sensitive potassium channels in rat renal vasculature.
- Effect of sarpogrelate and high-dose statin on the reduction of coronary spasm in vasospastic angina: A two by two factorial, pilot randomized study
|
| is cites work
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)